Abstract
Some unsolved problems--late onset of anemia and growth retardation (at age 7 years), healthy siblings showing very low transferrin (TF) level, and unexplained mode of inheritance--were found in family members of a congenital atransferrinemia already reported in 1972. The long-term clinical, laboratory, and developmental observations revealed that after 5 years of apo-TF supplementary therapy the patient's anemia gradually disappeared, and he started to grow again without further therapy. Immunoelectrophoretic study disclosed a severe deficiency of both TF and haptoglobin in the patient. The recovery from his anemia and the resumption of his physical development were dependent only on his TF level: that is, from a negligible level it increased to 10-20 mg/dl (normal, 205-370 mg/dl), a level similar to that of his TF-deficient siblings, who had been in good health since birth. The TF analysis of the patient and his family suggests that the minimum TF requisite in this family may be close to 10-20 mg/dl; subjects with more than 20 mg/dl are apparently healthy; with less than 10 mg/dl they may develop severe growth retardation and anemia, and extreme deficiency may be lethal. Also, coexisting haptoglobin deficiency might alleviate hemosiderosis. Further, the isoelectric focusing study disclosed that there was only a small amount of TF variant in these siblings including the patient. The study of the family confirmed that this variant was produced by an allelic gene derived from their father. So, the original diagnosis of congenital atransferrinemia should be revised as familial hypotransferrinemia transmitted with autosomal recessive mode, and the subjects with a recessive character may be compound heterozygotes of the "variant" allele and the "null" allele.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barnes D., Sato G. Serum-free cell culture: a unifying approach. Cell. 1980 Dec;22(3):649–655. doi: 10.1016/0092-8674(80)90540-1. [DOI] [PubMed] [Google Scholar]
- Bernstein S. E. Hereditary hypotransferrinemia with hemosiderosis, a murine disorder resembling human atransferrinemia. J Lab Clin Med. 1987 Dec;110(6):690–705. [PubMed] [Google Scholar]
- Cáp J., Lehotská V., Mayerová A. Kongenitálna atransferinémia u 11-mesacného dietata. Cesk Pediatr. 1968 Oct;23(11):1020–1025. [PubMed] [Google Scholar]
- Ekblom P., Thesleff I., Saxén L., Miettinen A., Timpl R. Transferrin as a fetal growth factor: acquisition of responsiveness related to embryonic induction. Proc Natl Acad Sci U S A. 1983 May;80(9):2651–2655. doi: 10.1073/pnas.80.9.2651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goya N., Miyazaki S., Kodate S., Ushio B. A family of congenital atransferrinemia. Blood. 1972 Aug;40(2):239–245. [PubMed] [Google Scholar]
- HEILMEYER L., KELLER W., VIVELL O., KEIDERLING W., BETKE K., WOEHLER F., SCHULTZE H. E. [Congenital atransferrinemia in a 7-year-old girl]. Dtsch Med Wochenschr. 1961 Sep 15;86:1745–1751. doi: 10.1055/s-0028-1113001. [DOI] [PubMed] [Google Scholar]
- Hamill R. L., Woods J. C., Cook B. A. Congenital atransferrinemia. A case report and review of the literature. Am J Clin Pathol. 1991 Aug;96(2):215–218. doi: 10.1093/ajcp/96.2.215. [DOI] [PubMed] [Google Scholar]
- Heilmeyer L. Die Atransferrinämien. Acta Haematol. 1966;36(1):40–49. doi: 10.1159/000209090. [DOI] [PubMed] [Google Scholar]
- Huggenvik J. I., Craven C. M., Idzerda R. L., Bernstein S., Kaplan J., McKnight G. S. A splicing defect in the mouse transferrin gene leads to congenital atransferrinemia. Blood. 1989 Jul;74(1):482–486. [PubMed] [Google Scholar]
- Huggenvik J. I., Idzerda R. L., Haywood L., Lee D. C., McKnight G. S., Griswold M. D. Transferrin messenger ribonucleic acid: molecular cloning and hormonal regulation in rat Sertoli cells. Endocrinology. 1987 Jan;120(1):332–340. doi: 10.1210/endo-120-1-332. [DOI] [PubMed] [Google Scholar]
- Loperena L., Dorantes S., Medrano E., Berrón R., Vega L., Cuarón A., Rodríguez C., Márquez J. L. Atransferrinemia hereditaria. Bol Med Hosp Infant Mex. 1974 May-Jun;31(3):519–535. [PubMed] [Google Scholar]
- Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
- Pascali V. L., Ranalletta D., Auconi P. Improved typing of human serum transferrin by isoelectric focusing on ultrathin layer polyacrylamide slab gels. Hum Genet. 1982;61(1):39–41. doi: 10.1007/BF00291329. [DOI] [PubMed] [Google Scholar]
- Reeves W. B., Haurani F. I. Clinical applicability and usefulness of ferritin measurements. Ann Clin Lab Sci. 1980 Nov-Dec;10(6):529–535. [PubMed] [Google Scholar]
- SMITHIES O. Variations in human serum beta-globulins. Nature. 1957 Dec 28;180(4600):1482–1483. doi: 10.1038/1801482a0. [DOI] [PubMed] [Google Scholar]
- Smith A. L., Weber A. Pharmacology of chloramphenicol. Pediatr Clin North Am. 1983 Feb;30(1):209–236. doi: 10.1016/s0031-3955(16)34330-9. [DOI] [PubMed] [Google Scholar]
- Walbaum R. Déficit congénital en transferrine. Lille Med. 1971 Oct;16(8):1122–1124. [PubMed] [Google Scholar]